Lesinurad/Allopurinol 200/300 FDC Tablets Bioequivalence
NCT02888054
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
28
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
lesinurad/allopurinol 200/300 FDC tablet
DRUG:
lesinurad 200 mg
DRUG:
allopurinol 300 mg
Sponsor
Ardea Biosciences, Inc.